Stock Events

Stock Events

Zai Lab Limited 

€2.02
48
-€0.08-3.81%Tuesday 07:05

Statistics

Day High
2.02
Day Low
2.02
52W High
2.3
52W Low
1.48
Volume
0
Avg. Volume
132
Mkt Cap
250.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q1 2026
Q2 2026
Q3 2026
-0.06
-0.05
-0.04
-0.04
Expected EPS
-0.0513443636499042
Actual EPS
-0.0365030138642832

Financials

-38.29%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
399.39MRevenue
-152.93MNet Income

Analyst Ratings

$34.15Average Price Target
The highest estimate is ⁦34.15⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1ZLB.MU. It's not an investment recommendation.
Microsoft
11
MSFT
NVIDIA
10
NVDA
Meta Platforms
10
META
Alibaba Group
10
BABA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CytomX Therapeutics
CTMX
Mkt Cap509.88M
CytomX Therapeutics operates in the field of oncology, developing Probody therapeutics for the treatment of cancer, competing with Zai Lab's oncology focus.
Exelixis
EXEL
Mkt Cap16.93B
Exelixis is a biotechnology company focused on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers, competing with Zai Lab.
Incyte
INCY
Mkt Cap24.54B
Incyte Corporation specializes in oncology and inflammation, with a portfolio that competes with Zai Lab's product offerings.
Arvinas
ARVN
Mkt Cap513.94M
Arvinas is pioneering the use of proteolysis targeting chimeras (PROTACs) to degrade disease-causing proteins, competing in the innovative treatment space with Zai Lab.
Allogene Therapeutics
ALLO
Mkt Cap407.68M
Allogene Therapeutics focuses on the development of allogeneic CAR T therapies for cancer, which places it in direct competition with Zai Lab's oncology focus.
Novartis
NVS
Mkt Cap303.67B
Novartis is a large pharmaceutical company with a broad oncology portfolio, competing on a global scale with Zai Lab in multiple therapeutic areas.

About

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Show More
CEO
Ying Du
Employees
1797
Country
China
ISIN
KYG9887T1168
WKN
000A3DJSH

Listings

MX
MX
ZLABN.MX
STU
DE
1ZLB.STU
STU
DE
1ZL.STU
STU
DE
1ZLA.STU

0 Comments

Share your thoughts

FAQs

What is Zai Lab Limited stock price today?▼
The current price of 1ZLB.MU is €2.02 EUR — it has decreased by -3.81% in the past 24 hours. Watch Zai Lab Limited stock price performance more closely on the chart.
What is Zai Lab Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Zai Lab Limited stocks are traded under the ticker 1ZLB.MU.
Is Zai Lab Limited stock price growing?▼
1ZLB.MU stock has fallen by -3.81% compared to the previous week, the month change is a -12.17% fall, over the last year Zai Lab Limited has showed a -2.88% decrease.
What is Zai Lab Limited market cap?▼
Today Zai Lab Limited has the market capitalization of 250.77M
When is the next Zai Lab Limited earnings date?▼
Zai Lab Limited is going to release the next earnings report on March 2, 2027.
What were Zai Lab Limited earnings last quarter?▼
1ZLB.MU earnings for the last quarter are -0.04 EUR per share, whereas the estimation was -0.05 EUR resulting in a +28.91% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Zai Lab Limited revenue for the last year?▼
Zai Lab Limited revenue for the last year amounts to 399.39M EUR.
What is Zai Lab Limited net income for the last year?▼
1ZLB.MU net income for the last year is -152.93M EUR.
How many employees does Zai Lab Limited have?▼
As of November 8, 2026, the company has 1,797 employees.
In which sector is Zai Lab Limited located?▼
Zai Lab Limited operates in the Health & Wellness sector.
When did Zai Lab Limited complete a stock split?▼
Zai Lab Limited has not had any recent stock splits.
Where is Zai Lab Limited headquartered?▼
Zai Lab Limited is headquartered in SHANGHAI, China.